Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
Heart failure (HF) is a serious and advanced stage of various cardiac diseases with high mortality and rehospitalization rates. Phosphoglycerate mutase 2 (PGAM2) overexpression was identified in the serum of patients with HF.
Guardado en:
Autores principales: | Li Min, Gao Xiaoyuan, Wang Huiyun, Zhang Mingli, Li Xiaoying, Wang Shuya, Wang Shaoqin, Cao Chongfeng, Li Ying, Su Guohai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29461ea7ccd74bef9469d19c10243361 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Macrocycle peptides delineate locked-open inhibition mechanism for microorganism phosphoglycerate mutases
por: Hao Yu, et al.
Publicado: (2017) -
3D-QSAR, Molecular Docking, and MD Simulations of Anthraquinone Derivatives as PGAM1 Inhibitors
por: Yuwei Wang, et al.
Publicado: (2021) -
Improvement in Atrial Fibrillation-Related Symptoms After Cardioversion: Role of NYHA Functional Class and Maintenance of Sinus Rhythm
por: Ferre-Vallverdu M, et al.
Publicado: (2021) -
Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
por: Imperiali Claudia E., et al.
Publicado: (2020) -
Role of Cardiac Biomarkers in Cancer Patients
por: Gennaro Carmine Semeraro, et al.
Publicado: (2021)